The detachment and subsequent central embolisation of an intravenous catheter is a serious event which may give rise to complications such as vascular perforation, thrombosis, or endocarditis. Catheter embolisation now occurs with increasing frequency because of increasing use of central lines. We have recently removed the embolised portions of intravenous catheters from five patients, using a radiological technique and thereby obviating the need for thoracic surgery.
Patients, methods, and results
Case report-A 13 year old girl in first remission of acute myeloid leukaemia was admitted for further chemotherapy. A Hickman paediatric catheter (Evergreen Medical Products Inc, Washington, USA) was inserted into the right cephalic vein under general anaesthesia. Initially the catheter functioned well but 18 hours after insertion it became blocked. When we tried to remove the catheter its distal 14 cm segment remained within the patient and a chest radiograph showed that it had embolised to the pulmonary arterial tree. The patient had no symptoms but in order to avert later complications' we decided to remove the detached fragment using a percutaneous radiological technique. A steerable catheter (Medi-tech) the heart into the pulmonary artery, and retrieval of the missing line was considerably more difficult in these cases than in the remainder, where the line was still in the superior vena cava or right atrium. This was because of the additional catheter manipulation required to enter the pulmonary artery and also because it proved difficult to pull the ensnared fragment back through the pulmonary and tricuspid valves. It is therefore important to try to remove a detached intravenous catheter at the earliest opportunity, when it may still lie in a relatively accessible site proximal to the tricuspid valve.
In all but one of these cases the lines were inserted strictly in accordance with the manufacturer's instructions; in the one exception a Nutricath catheter was partly severed by a cutaneous stitch.
Comment
Indwelling catheters inserted into the cephalic, subclavian, or jugular veins are routinely used for the administration of parenteral nutrition, cytotoxic agents, and blood products and measurement of central venous pressure. Although catheter embolisation was first reported as a complication of indwelling lines in 1954,3 it seems to be relatively uncommon: in a study of 355 central venous catheters used for total parenteral nutrition in 200 patients4 the major complications noted were related to catheter sepsis (25 catheters (7%) and 22 patients) and to catheter insertion (14 catheters (4%) and 12 patients); no mention was made of catheter embolisation. One series of 29 cases has been reported,5 however, and a recent review' emphasised the hazards of retained catheter fragments: the overall potential risk of serious complications in that report was 71%.
One practical problem encountered during these five procedures was difficulty in visualising the detached catheter fragments at fluoroscopy, which would have been easier had the catheters been more radio-opaque
We think that the detachment and embolisation of intravenous catheter fragments is occurring more frequently. The use of noninvasive radiological techniques, as described here, should obviate the need for major thoracic surgery in most cases. Patients, methods, and results Thirty men and women aged over 18 with endoscopically proved active chronic duodenal ulcers and no gastric ulceration were included in the study. Patients who had had previous gastric surgery or taken cimetidine within the previous six weeks were excluded. Patients were randomly allocated to receive cimetidine 200 mg thrice daily and 400 mg at night either for six weeks or for a minimum of one week and thereafter only until their symptoms had completely resolved. Antacid tablets (Gelusil, William Warners) were supplied to be taken as dictated by symptoms. All patients completed diary cards giving details of ulcer pain and the number of both cimetidine and antacid tablets taken. They attended the outpatient clinic every fortnight while taking cimetidine and then every four weeks until either three months after treatment was started or their symptoms recurred, whichever came first. At that stage endoscopy was repeated.
Sixteen patients took cimetidine for six weeks and 14 until their symptoms were relieved. There were no significant differences between the groups in sex distribution, age, alcohol consumption, or smoking. The 
Treatment with cimetidine was initially expected to modify the behaviour of duodenal ulcer disease. The rate of recurrence of duodenal ulcers after a healing course of cimetidine, however, is similar to the 8-5% per month seen in ulcers healed by placebo.' Thus, once completed, a course of cimetidine has no influence on the natural history of duodenal ulcer disease. The rate of recurrence may be reduced to 2-5% per month by giving maintenance treatment of 400 mg at bedtime indefinitely, but asymptomatic recurrence is a hazard in this group; in one study 9-6% of patients had endoscopically proved asymptomatic recurrences while taking 400 mg at bedtime after their duodenal ulcers had first healed.'
Our study showed that three months after the start of treatment or when symptoms recurred, whichever came first, there were no important differences between patients who had taken cimetidine for six weeks and those who had taken it only until their symptoms were relieved. The healing rates were 56% and 57% respectively. We did not determine the initial healing rates at the time cimetidine was stopped, which explains the discrepancy between our figures and the 77% healing rate for cimetidine treated ulcers found in another study on completion of treatment.'
From our results we suggest that patients with active duodenal ulcers may be advised to take cimetidine only until their symptoms are controlled. Further studies are necessary to examine this approach to prescribing over periods longer than three months. Interstitial nephritis with acute renal failure after erythromycin
Erythromycin is a relatively safe, widely used antibiotic and is reportedly free of nephrotoxic effects. We, however, report an acute interstitial nephritis after its use.
Case report A 39 year old woman was admitted to the Beilinson Medical Center because of anaemia and generalised weakness. Her past history included an attack of rheumatic fever at the age of 6. Over the past few years she had been completely well and had received only symptomatic treatment for occasional upper respiratory tract infections. The drugs used included codeine phosphate, amidopyrine, and phenacetin. For several weeks before admission she had been taking erythromycin for recurrent tonsillitis. There was no history of skin eruptions.
On admission her blood pressure was 120/80 mm Hg, and except for obvious anaemia the only positive findings were an aortic ejection sound and a diastolic murmur at the apex. No orbital or peripheral oedema was observed. She had no rash, arthralgia, or peripfieral blood eosinophilia. Light microscopical appearances of percutaneous kidney biopsy specimen showing mononuclear infiltration and tubular atrophy. The patient's condition deteriorated and the serum creatinine concentration rose to 672 itmol/l (7-6 mg/100 ml). Prednisone 30 mg/day was instituted and the blood urea nitrogen and serum creatinine concentrations decreased progressively. Eight weeks later the serum creatinine concentration was 230 ,umol/l (2.6 mg/100 ml). Azathioprine 100 mg/day was added. This treatment was given for four weeks, by which time the serum creatinine value had fallen to 159 ,umol/l (1-8 mg/100 ml). Azathioprine was then stopped. Prednisone was gradually reduced and eventually stopped after a total of five months of treatment. Serum creatinine concentrations six, 12, and 36 months after stopping prednisone remained stable at 141 tmol/l (1-6 mg/100 ml). The urinary sediment retumed to normal within two months of starting prednisone and remained normal.
Macrophage migration inhibition tests with the patient's lymphocytes and macrophages from the peritoneal cavity of guinea pigs were performed by a modification of Rajapakse's technique.' Reactions to the following drugs were measured: codeine phosphate, caffeine, amidopyrine, phenacetin, ampicillin, and erythromycin. The only positive reaction was when the patient's lymphocytes were challenged with erythromycin. Lymphocytes from five patients who had received erythromycin for a week or more without side effects did not-inhibit macrophage migration.
Our patient presented with anaemia and weakness and was found to have severe renal failure. Renal biopsy appearances were compatible with interstitial nephritis. Besides erythromycin no other drug or agent could be implicated.
Acute interstitial nephritis occurs in many conditions that include a cellular immune reaction as a common denominator. Drugs described as causing interstitial nephritis include thiazide,2 phenazone, penicillin, methicillin, ampicillin, phenindione, sulphasalazine, and allopurinol.3 In this study we showed that erythromycin triggered the patient's sensitised lymphocytes to release migration inhibitory factor. This suggests that erythromycin may well also have triggered the lymphocyte infiltration of the renal interstitium.
The only other report where erythromycin was suggested as causing interstitial nephritis was published in 19804; biopsy was not performed, however, and the diagnosis was made on clinical grounds alone. Van Ypersele de Strihou described acute oliguric interstitial nephritis but did not mention erythromycin as a cause ofthe condition.3
